ClinicalTrials.Veeva

Menu

Impact of Vitamin D3 Supplementation in Non-Sjogren Dry Eye Patients With Low Serum Vitamin D Level

U

University of Faisalabad

Status and phase

Completed
Phase 3

Conditions

Dry Eye Syndromes
Hypovitaminosis D

Treatments

Drug: Vitamin D
Drug: Artificial tear

Study type

Interventional

Funder types

Other

Identifiers

NCT05425914
TUF Faisalabad

Details and patient eligibility

About

Dry eye disease is multifactorial, ocular inflammatory condition causing irritation, stinging sensation, uneasiness and blurring. Non-Sjogren syndrome occurs due to absent or dysfunction of lacrimal gland. Fat soluble vitamin D act as an agent against inflammation and its deficiency may result in various inflammatory diseases including dry eye. Purpose of this study is evaluation of vitamin D3 supplementation role in treating non-Sjogren dry eye along with conventional treatment by using artificial tears in patients with hypovitaminosis D. A prospective study was conducted in Rural health center(RHC) Buchal Kalan on 108 patients presenting with non-Sjogren dry eyes and low serum vitamin D levels. Patients were subjected to the following examination; best corrected visual acuity (BCVA), slit-lamp examination, applanation tonometry, fundoscopy, tear breakup time (TBUT) after fluorescein staining, Schirmer tear test, numerical pain rating scale (NPRS) and ocular surface disease index (OSDI) score on day 0, 15, 30, 60 and 90. Vitamin D levels was assessed by electrochemiluminescence immunoassay (ECLIA) based analyzer. The sample was randomly divided into two groups by non-probability purposive sampling. Group 1 received only artificial tears 4times/day while group 2 were given oral vitamin D3 supplementation of 6000 international unit (IU) daily along with artificial tears. Impact of oral vitamin D3 supplementation on non-Sjogren dry eyes was assessed by comparing means of ocular parameters of both groups over different period of time by using Mann-Whitney Test and Friedman Test.

Enrollment

108 patients

Sex

All

Ages

20 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with non-Sjogren dry eyes with low serum vitamin D level.
  • Both gender.
  • Age group will be 20-50 years of age.
  • Cooperative patients.

Exclusion criteria

  • Autoimmune diseases (such as Sjogren syndrome and lupus syndrome).
  • All ocular pathologies except dry eyes.
  • All systemic pathologies that affects tear layers.
  • All non- cooperative patients.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

108 participants in 2 patient groups

Conventional Treatment
Active Comparator group
Description:
Receiving conventional dry eye treatment in the form of artificial tears four times per days for 90 days.
Treatment:
Drug: Artificial tear
Vitamin D3 Supplementation
Experimental group
Description:
Receiving vitamin d3 supplementation 6000IU per day along with artificial tears for 90 days.
Treatment:
Drug: Vitamin D
Drug: Artificial tear

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems